APA (7th ed.) Citation

F, C., EC, V., Z, D., D, K., TF, H., G, Z., . . . WWMP, P. (2024). Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage. Human gene therapy, 35(7-8), 256. https://doi.org/10.1089/hum.2023.177

Chicago Style (17th ed.) Citation

F, Catalano, et al. "Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage." Human Gene Therapy 35, no. 7-8 (2024): 256. https://doi.org/10.1089/hum.2023.177.

MLA (9th ed.) Citation

F, Catalano, et al. "Lentiviral Gene Therapy for Mucopolysaccharidosis II with Tagged Iduronate 2-Sulfatase Prevents Life-Threatening Pathology in Peripheral Tissues But Fails to Correct Cartilage." Human Gene Therapy, vol. 35, no. 7-8, 2024, p. 256, https://doi.org/10.1089/hum.2023.177.